NEOCUTIS SA has a total of 35 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Canada, China and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are Reoxcyn LLC, ZOUBOULIS CHRISTOS C and LEGACY HEALTHCARE HOLDING LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | China | 5 | |
#3 | Republic of Korea | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Australia | 2 | |
#7 | Hong Kong | 2 | |
#8 | Taiwan | 2 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | Singapore | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Dreher Frank | 21 |
#2 | Hohlfeld Patrick | 9 |
#3 | Laurent-Applegate Lee | 5 |
#4 | Laurent-Applegate Leo | 3 |
#5 | Dreher Frank F | 2 |
#6 | Patrick Hohlfeld | 2 |
#7 | Lee Laurent Applegate | 1 |
#8 | Lee Laurent-Applegate | 1 |
#9 | Laurent Applegate Lee | 1 |
Publication | Filing date | Title |
---|---|---|
TW201532621A | Antioxidant compositions and methods of using the same | |
KR20150126621A | Peptides for skin rejuvenation and methods of using the same | |
CA2790682A1 | Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds | |
CA2748375A1 | Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions | |
EP1799235A2 | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same | |
CN101132804A | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same | |
CN1638822A | Compositions comprising undifferentiated fetal cells for the treatment of skin disorders |